262 related articles for article (PubMed ID: 12638939)
1. Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease.
Zeng BJ; Wang ZH; Ribeiro LA; Leone P; De Gasperi R; Kim SJ; Raghavan S; Ong E; Pastores GM; Kolodny EH
J Inherit Metab Dis; 2002 Nov; 25(7):557-70. PubMed ID: 12638939
[TBL] [Abstract][Full Text] [Related]
2. Canavan disease: mutations among Jewish and non-Jewish patients.
Kaul R; Gao GP; Aloya M; Balamurugan K; Petrosky A; Michals K; Matalon R
Am J Hum Genet; 1994 Jul; 55(1):34-41. PubMed ID: 8023850
[TBL] [Abstract][Full Text] [Related]
3. Identification and expression of eight novel mutations among non-Jewish patients with Canavan disease.
Kaul R; Gao GP; Matalon R; Aloya M; Su Q; Jin M; Johnson AB; Schutgens RB; Clarke JT
Am J Hum Genet; 1996 Jul; 59(1):95-102. PubMed ID: 8659549
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of aspartoacylase: implications for Canavan disease.
Hershfield JR; Pattabiraman N; Madhavarao CN; Namboodiri MA
Brain Res; 2007 May; 1148():1-14. PubMed ID: 17391648
[TBL] [Abstract][Full Text] [Related]
5. Canavan disease: genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution.
Kaul R; Balamurugan K; Gao GP; Matalon R
Genomics; 1994 May; 21(2):364-70. PubMed ID: 8088831
[TBL] [Abstract][Full Text] [Related]
6. Mutation detection in the aspartoacylase gene in 17 patients with Canavan disease: four new mutations in the non-Jewish population.
Sistermans EA; de Coo RF; van Beerendonk HM; Poll-The BT; Kleijer WJ; van Oost BA
Eur J Hum Genet; 2000 Jul; 8(7):557-60. PubMed ID: 10909858
[TBL] [Abstract][Full Text] [Related]
7. Canavan disease: a novel mutation.
Schober H; Luetschg J; Hoeliner I; Kalb S; Simma B
Pediatr Neurol; 2011 Oct; 45(4):256-8. PubMed ID: 21907889
[TBL] [Abstract][Full Text] [Related]
8. Novel splice site mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
Rady PL; Penzien JM; Vargas T; Tyring SK; Matalon R
Eur J Paediatr Neurol; 2000; 4(1):27-30. PubMed ID: 10701101
[TBL] [Abstract][Full Text] [Related]
9. The spectrum of mutations of the aspartoacylase gene in Canavan disease in non-Jewish patients.
Elpeleg ON; Shaag A
J Inherit Metab Dis; 1999 Jun; 22(4):531-4. PubMed ID: 10407784
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis of the aspartoacylase gene in non-Jewish patients with Canavan disease.
Zeng BJ; Pastores GM; Leone P; Raghavan S; Wang ZH; Ribeiro LA; Torres P; Ong E; Kolodny EH
Adv Exp Med Biol; 2006; 576():165-73; discussion 361-3. PubMed ID: 16802711
[No Abstract] [Full Text] [Related]
11. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease.
Kaul R; Gao GP; Balamurugan K; Matalon R
Nat Genet; 1993 Oct; 5(2):118-23. PubMed ID: 8252036
[TBL] [Abstract][Full Text] [Related]
12. The molecular basis of canavan (aspartoacylase deficiency) disease in European non-Jewish patients.
Shaag A; Anikster Y; Christensen E; Glustein JZ; Fois A; Michelakakis H; Nigro F; Pronicka E; Ribes A; Zabot MT
Am J Hum Genet; 1995 Sep; 57(3):572-80. PubMed ID: 7668285
[TBL] [Abstract][Full Text] [Related]
13. Two novel aspartoacylase gene (ASPA) missense mutations specific to Norwegian and Swedish patients with Canavan disease.
Olsen TR; Tranebjaerg L; Kvittingen EA; Hagenfeldt L; Møller C; Nilssen O
J Med Genet; 2002 Sep; 39(9):e55. PubMed ID: 12205125
[No Abstract] [Full Text] [Related]
14. Canavan disease: diagnosis and molecular analysis.
Matalon R
Genet Test; 1997; 1(1):21-5. PubMed ID: 10464621
[TBL] [Abstract][Full Text] [Related]
15. A novel aspartoacylase (ASPA) gene mutation in Canavan disease.
Durmaz AA; Akin H; Onay H; Vahabi A; Ozkinay F
Fetal Pediatr Pathol; 2012 Aug; 31(4):236-9. PubMed ID: 22468686
[TBL] [Abstract][Full Text] [Related]
16. Rapid detection of three large novel deletions of the aspartoacylase gene in non-Jewish patients with Canavan disease.
Zeng BJ; Wang ZH; Torres PA; Pastores GM; Leone P; Raghavan SS; Kolodny EH
Mol Genet Metab; 2006; 89(1-2):156-63. PubMed ID: 16854607
[TBL] [Abstract][Full Text] [Related]
17. Novel mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
Unalp A; Altiok E; Uran N; Oztürk A; Yüksel S
J Trop Pediatr; 2008 Jun; 54(3):208-10. PubMed ID: 17999961
[TBL] [Abstract][Full Text] [Related]
18. Frequency of a DNA polymorphism at position Y231 in the aspartoacylase gene and its impact on DNA-based carrier testing for Canavan disease in the Ashkenazi Jewish Population.
Alford RL; DeMarchi JM; Richards CS
Hum Mutat; 1998; Suppl 1():S161-2. PubMed ID: 9452075
[No Abstract] [Full Text] [Related]
19. Canavan disease: an Arab scenario.
Zayed H
Gene; 2015 Apr; 560(1):9-14. PubMed ID: 25668701
[TBL] [Abstract][Full Text] [Related]
20. New T530C mutation in the aspartoacylase gene caused Canavan disease with no correlation between severity and N-acetylaspartate excretion.
Di Pietro V; Cavallari U; Amorini AM; Lazzarino G; Longo S; Poggiani C; Cavalli P; Tavazzi B
Clin Biochem; 2013 Dec; 46(18):1902-4. PubMed ID: 24036223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
